Results 171 to 180 of about 255,505 (337)
GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu +11 more
wiley +1 more source
Significance of EVs in Prostate Cancer Bone Metastases. [PDF]
Ito K +6 more
europepmc +1 more source
Iatrogenic Alterations of Immunologic Surveillance in Man and Their Influence on Malignancy [PDF]
Agosin M. +85 more
core +1 more source
Depletion of the RNA‐Editing Enzyme ADAR1 Invigorates the Antitumor Immunity of NK Cells
ADAR1 is upregulated in NK cells from melanoma patients, impairing their function. Its loss enhances NK cell tumor infiltration and cytotoxicity in vitro and in vivo. Mechanistically, ADAR1 deficiency destabilizes CD38 mRNA to reduce its expression, thereby increasing NK cell mobility and killing, which nominates it as a therapeutic target for NK cell ...
Shuhan Chen +11 more
wiley +1 more source
Microenvironmental and Molecular Pathways Driving Dormancy Escape in Bone Metastases. [PDF]
Bakir M +3 more
europepmc +1 more source
Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma. [PDF]
Andrew G. Hall +5 more
openalex +1 more source
Schematic model showing the suggested mechanism that ZA induces classical activation of macrophages by impairing mitochondrial biofunction and inhibiting mitochondrial clearance to contribute to the pathological process of BRONJ. RAPA‐loaded nanoparticles ZDPR has shown potential in alleviating BRONJ lesions as well as treating osteoporosis or ...
Hang Zhang +10 more
wiley +1 more source
Bone metastases from endocrine cancer: advances in diagnosis, treatment, and prevention. [PDF]
Huang S +6 more
europepmc +1 more source

